Duopic Paed 75 & 50 mg Tablets

    Duopic Paed 75 & 50 mg Tablets

    S4
    PDF Leaflet Revision Date: 18 November 2025


    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Pulmonary tuberculosis in children.

    Dosage (summary)

    Daily: Rifampicin 15 mg/kg (max 600 mg), Isoniazid 10 mg/kg (max 300 mg).

    Special Populations

    • Hepatic impairment
    • Renal impairment

    Pregnancy & Breastfeeding

    Safety not established; crosses placenta and excreted in breastmilk.

    Key Drug Interactions

    • Nevirapine
    • Saquinavir/Ritonavir
    • Corticosteroids
    • Warfarin

    Contraindications

    • Hypersensitivity to rifampicin or isoniazid
    • Jaundice
    • Severe renal/hepatic impairment

    Common side effects

    • Hepatotoxicity
    • Peripheral neuropathy
    • Gastrointestinal disturbances

    Counselling Points

    • Take on an empty stomach
    • Avoid alcohol
    • Monitor for jaundice or unusual bleeding

    Serious warnings

    • Serious hepatotoxicity
    • Hypersensitivity reactions
    • Monitor liver function
    Important Disclaimer

    The Duopic Paed 75 & 50 mg Tablets professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn